Last $9.97 USD
Change Today +0.091 / 0.92%
Volume 1.1M
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:55 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James P. Shaffer

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

47$1,100,512
As of Fiscal Year 2013

Background*

Mr. James P. Shaffer, also known as Jim, has been Consultant at Halozyme Therapeutics, Inc. since March 31, 2014. Mr. Shaffer served as Chief Commercial Officer and Vice President of Halozyme Therapeutics, Inc. until March 31, 2014. He joined Halozyme in 2011 with over 23 years of Commercial Operations experience. He has experience in both large and small pharmaceutical companies in the areas of Neurology, Psychiatry, Oncology, GI and Pulmonary Care with specialized ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
The Ohio State University
MBA
The Ohio State University

Other Affiliations*

Annual Compensation*

Salary$366,670
Total Annual Compensation$366,670

Stock Options*

Restricted Stock Awards$196,500
All Other Compensation$44,221
Exercisable Options111,804
Exercisable Options Value$704,298
Unexercisable Options154,863
Unexercisable Options Value$1,077,370
Total Value of Options$1,781,667
Total Number of Options266,667

Total Compensation*

Total Annual Cash Compensation$704,227
Total Short Term Compensation$366,670
Other Long Term Compensation$240,721
Total Calculated Compensation$1,100,512
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $9.97 USD +0.091

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.